We are live on
!
Find out more
TC
Tavio Capital Portfolio holdings
AUM
$75.4M
1-Year Est. Return
27.99%
This Fund
S&P 500
This Quarter
Est. Return
+20.63%
1 Year Est. Return
+27.99%
3 Year Est. Return
+81.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$271M
AUM Growth
+$82.1M
(+43%)
Cap. Flow
+$49M
Cap. Flow
% of AUM
18.05%
Top 10 Holdings %
Top 10 Hldgs %
95.32%
Holding
13
New
2
Increased
5
Reduced
4
Closed
1
Top Buys
| 1 |
Centene
CNC
|
+$26.2M |
| 2 |
Cigna
CI
|
+$22.8M |
| 3 |
HCA Healthcare
HCA
|
+$11.1M |
| 4 |
Baxter International
BAX
|
+$10M |
| 5 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$3.09M |
Top Sells
| 1 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$7.46M |
| 2 |
WMGI
Wright Medical Group Inc
WMGI
|
+$6.68M |
| 3 |
McKesson
MCK
|
+$5.91M |
| 4 |
Molina Healthcare
MOH
|
+$3.92M |
| 5 |
Labcorp
LH
|
+$3.23M |
Sector Composition
| 1 | Healthcare | 96.8% |
Similar funds
PC
EGPO
AIS
MCMT
NBG
FC
SCM
MVM
Tavio Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Tavio Capital held 13 positions worth $271M, up 43% from $189M the previous quarter. Its ten largest holdings account for 95% of the portfolio.
Tavio Capital deployed $49M of net new capital in Q4 2019, opening 2 new positions and adding to 5 existing holdings. Its largest new stake was Centene: 483,176 shares worth $30.4M.
By sector, the portfolio is most concentrated in Healthcare at 97% of assets, down from 97% a quarter earlier.
On the sell side, the largest reduction was Patterson Companies, Inc., an estimated $7.46M trimmed.
- Tavio Capital's largest Q4 2019 buy was Centene: 483,176 shares worth $30.4M.
- Tavio Capital added most to Cigna in Q4 2019, an estimated $22.8M increase.
- Tavio Capital's biggest Q4 2019 reduction was Patterson Companies, Inc., cutting an estimated $7.46M.
- Tavio Capital fully exited Wright Medical Group Inc in Q4 2019, selling an estimated $6.68M.
- Tavio Capital's ten largest holdings make up 95% of its $271M portfolio in Q4 2019.
- Tavio Capital opened 2 new positions and closed 1 in Q4 2019.
- Tavio Capital's portfolio value rose 43% quarter-over-quarter to $271M.
Based on Tavio Capital's 13F filing for Q4 2019, filed 13 Feb 2020.